Search
for
Sort by
Research 961–990 of 1000+
- Evaluation of ovarian reserve and function in female patients treated with oral isotretinoin for severe acne: an exploratory study
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
- Randomized Questionnaire Based Case–Control Research Study on Evaluation of Sexual Function in Indian Patients Taking Oral Finasteride for Androgenetic Alopecia
- Optimal laboratory testing protocol for patients with acne taking oral isotretinoin
- Evaluation of a novel dry eye model induced by oral administration of finasteride
- The Janus kinase 1 inhibitor abrocitinib for the treatment of oral lichen planus
- Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Oral Presentations
- Formulation and evaluation of self-nanoemulsifying drug delivery system for improved oral delivery of exemestane hydrochloride
- Azathioprine‐induced severe myelosuppression accompanied by massive hair loss and painful oral ulcer in an autoimmune hepatitis patient with <i>NUDT15</i> minor variant: A case report
- Photodynamic therapy as a new therapeutic approach of oral lichen planus
- Induction and reversal of pulmonary lipid histiocytosis in rats following oral administration of anorectics cloforex and chlorphentermine
- The Role of Vitamin D3 Deficiency and Colonization of the Oral Mucosa by Candida Yeast-like Fungi in the Pathomechanism of Psoriasis
- [Artículo traducido] Efectos adversos graves por errores de formulación de minoxidil oral a bajas dosis para el tratamiento de la alopecia
- Versatility of the inferiorly based nasolabial flap for reconstruction in early oral cancer patients: Our experience in a tertiary cancer centre
- Improvement in Scalp Hair in Middle Aged Women Using Oral Enzyme Food and Collagen
- Two Cases of Reversible Bilateral Painful Gynecomastia Induced by 1mg Oral Finasteride(Propecia$^{(R)})$
- Effective Treatment of Folliculitis Decalvans With a Combination of Oral Isotretinoin and Rifampicin
- Achievement of good long-term control with direct oral anticoagulant for Buerger’s disease
- [Retracted] Mechanism of Anti‐Inflammatory Drugs in the Early Treatment of Oral Gingival Mucosa and Soft Tissue Trauma
- Recent Advances in Cold Atmospheric Plasma for the Treatment of Oral Diseases
- Simultaneous Versus Delayed Initiation of Spironolactone and Low‐Dose Oral Minoxidil: Adverse Event Rates in a Retrospective Cohort Study
- A Proposed Microneedle–Small Extracellular Vesicle System for Localized Adjunctive Treatment of Established Oral Squamous Cell Carcinoma: A Narrative Review and Preclinical Development Perspective
- 76221 Faster Onset and Superior Efficacy of an Investigational Extended-Release Oral Minoxidil Tablet (VDPHL01) Versus Topical and Immediate-Release Oral Minoxidil for Androgenetic Alopecia: Results from a Blinded Retrospective Investigator Global Assessment
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Supplemental Materials for "No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study"
- Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"
- Supplemental Figure 1 for "Time to Maximal Response with Low-Dose Oral Minoxidil in Clinical Treatment of Androgenetic Alopecia"
- Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial